Novavax Inc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC NVAX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

248,989

Value ($000)

1,673

Weight

0.0%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,673	0.0%	248,989	12/31/2025
2025 Q3	11/14/2025	2,511	0.0%	289,674	9/30/2025
2025 Q2	8/14/2025	2,807	0.0%	445,587	6/30/2025
2025 Q1	5/19/2025	2,005	0.0%	312,789	3/31/2025
2024 Q4	2/14/2025	2,160	0.0%	268,684	12/31/2024
2024 Q3	11/14/2024	2,833	0.0%	224,325	9/30/2024
2024 Q2	8/14/2024	3,226	0.0%	254,780	6/30/2024
2024 Q1	5/15/2024	411	0.0%	86,065	3/31/2024
2023 Q4	2/14/2024	340	0.0%	70,793	12/31/2023
2023 Q3	11/13/2023	726	0.0%	100,214	9/30/2023
2023 Q2	8/11/2023	922	0.0%	133,084	6/30/2023
2023 Q1	5/15/2023	922	0.0%	133,084	3/31/2023
2022 Q4	2/14/2023	1,022	0.0%	99,432	12/31/2022
2022 Q3	11/14/2022	1,803	0.0%	99,084	9/30/2022
2022 Q2	8/12/2022	6,028	0.0%	117,205	6/30/2022
2022 Q1	5/16/2022	16,201	0.0%	219,967	3/31/2022
2021 Q4	2/14/2022	31,340	0.0%	219,052	12/31/2021
2021 Q3	11/15/2021	45,685	0.0%	220,370	9/30/2021
2021 Q2	8/16/2021	62,776	0.0%	295,683	6/30/2021
2021 Q1	5/14/2021	31,172	0.0%	171,924	3/31/2021
2020 Q4	3/1/2021	23,051	0.0%	206,716	12/31/2020
2020 Q3	11/13/2020	18,260	0.0%	168,531	9/30/2020
2020 Q2	8/14/2020	3,867	0.0%	46,396	6/30/2020